Share This Page

Scammability – Dementia’s Newest Warning Sign

Phone Scam
ELDER ABUSE (VIDEO + ARTICLE): Scammability, or ease of getting scammed, is a warning sign for dementia. Caused by loss of social judgement, it occurs before thinking or memory problems. (Video+Article)

Low scam awareness in older people is associated with risk for developing Alzheimer dementia or mild cognitive impairment in the future. These findings suggest that changes in social judgment occur before changes in thinking or memory are recognizable. Findings from a prospective cohort study are published in Annals of Internal Medicine.

Identifying predictors of dementia and mild cognitive impairment is critically important, but which aspects of behavior to target remains unclear. Older adults frequently are targeted by con-artists and are highly vulnerable to scams and fraud, particularly those that are financial in nature. However, little is known about whether scam awareness predicts transitions from normality to mild cognitive impairment and dementia.

Scam Awareness Questionnaire

Researchers from Rush Alzheimer’s Disease Center in Chicago asked 935 older persons to complete a “scam awareness questionnaire” when all were free from dementia to ascertain a scam awareness score. Over an average of 6 years of follow up, participants also completed traditional neuropsychological tests every year, and the 264 participants who died had an autopsy of the brain to look for the hallmarks of Alzheimer disease. The researchers found that low scam awareness was a harbinger of adverse cognitive outcomes. Low scam awareness was also associated with Alzheimer disease pathology in the brain. According to the researchers, these findings suggest that low scam awareness is an early sign of impending mild cognitive impairment and dementia. Further, they conclude that evaluation of behaviors such as scam awareness may help to identify individuals at risk for dementia before cognitive symptoms manifest.

Scammed Out of Life’s Savngs

According to the author of an accompanying editorial, this study provides new information about social cognition as it relates to aging. The author provides an example of a patient who was scammed out of the majority of his life savings by a slick fraudster who tricked him into thinking he had won the lottery.

Call to Action for Healthcare

Diminished financial capacity, financial abuse, and exploitation are major economic and public health problems. An older adult who is defrauded may end up unable to pay for medications, food, and long-term care, the author wrote. As such, the findings from this study should be a call to action for health care systems, the financial services industry, and their regulators to protect the health and wealth of our aging population.

Related:

Email me when people comment
Notify of
guest

1 Comment
Inline Feedbacks
View all comments
Mareva
Mareva
June 2, 2024 5:48 pm

What about the Memory Care facilities that have their own version of Dementia not the Alzheimer version thereby leaving many residents with Dementia without suitable activities for hearing loss etc and no activities or social interactions. No one accommodates these people. They charge a high price for doing half the job.

Edited by:
Picture of P. Berger

P. Berger

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Share this page To

You May LIke:

laboratory, analysis, chemistry
Clinical Trials

FDA Okays Trial of Alzheimer’s Pill with Unique Mechanism

The new Alzheimer’s injections Aduhelm and Lecanemab offer hope. Now, Mastinimab is trying to break through to the next level with a simpler pill. Mastinimab fights Alzheimer’s via a revolutionary mechanism of action. Learn why the FDA approved Mastinimab’s final round of trials.

Read More »
Share to Facebook
Twitter
LinkedIn

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Visit Alzheimer's Weekly On

1
0
Would love your thoughts, please comment.x
()
x
News, Treatments, Care Tips, Diet

Alzheimer's & Dementia Weekly Newsletter: Free

Free. Care & Treatment. Research & Prevention

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

News to Get at the Truth

Subscribe To Our Weekly Newsletter